Durham, NC, United States of America

Linda M Thurmond

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Glaxosmithkline LLC. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linda M Thurmond. Retrieved from https://idiyas.com/inventor/linda-m-thurmond

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Linda M. Thurmond

Introduction

Linda M. Thurmond is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 2 patents, her work focuses on innovative combinations of antibodies and chemotherapeutic agents.

Latest Patents

Linda's latest patents include a groundbreaking combination of an anti-EP-CAM antibody with a chemotherapeutic agent. This combination is designed to effectively arrest Ep-CAM antigen expressing cells in the S or G/M phases of the cell cycle. Her second patent also revolves around a similar concept, emphasizing the potential of this combination in enhancing cancer therapies.

Career Highlights

Linda is currently employed at GlaxoSmithKline LLC, where she continues to push the boundaries of medical research and innovation. Her work has the potential to significantly impact cancer treatment protocols and improve patient outcomes.

Collaborations

Some of her notable coworkers include Vincent C. Knick and Julie Beth Stimmel, who contribute to her research endeavors.

Conclusion

Linda M. Thurmond's innovative work in the field of biotechnology exemplifies the importance of combining scientific research with practical applications in medicine. Her contributions are paving the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…